Mesa Laboratories, Inc. Delays Earnings Announcement for the Fourth Quarter and Full Fiscal Year 2024 Results
May 22, 2024 at 06:00 am EDT
Share
Mesa Laboratories, Inc. announced that it will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on May 31, 2024. Mesa?s Form 10-K will be filed the same day. The earnings announcement has been delayed as the company finalize the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill related to Clinical Genomics and Biopharmaceutical Development divisions.
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.